eNews
Home page > Comments


Comments

Canadian health regulators approve InterMune's fibrosis drug

03.10.2012. | (Reuters) - Biotechnology company InterMune Inc said Canadian health regulators approved its drug to treat idiopathic pulmonary fibrosis, a fatal lung disease....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: